Introduction
============

Seaweed, including laver, is a standard food consumed in Asian countries, including Korea and Japan. Several studies have reported that seaweed has various bioactive substances with anticancer, antiviral and anticoagulant effects ([@b1-ijmm-42-02-0789]-[@b5-ijmm-42-02-0789]). The majority of studies on seaweed bioactivity have investigated solvent extracts, rather than mono-constituent substances, and there has been limited investigation of seaweed proteins and peptides ([@b6-ijmm-42-02-0789]). Previous studies have progressed our understanding of the bioactive components in seaweed, including the partial creation of a seaweed protein database, identification of a seaweed protein that changes according to stress and environment, proteomic investigations on its usefulness as a biomarker, and the development of a DNA marker based on the genomic sequence of the laver *Pyropia* species ([@b7-ijmm-42-02-0789]). However, there remains a paucity of basic information describing the activity and function of the bioactive components of seaweed.

The most prominent characteristic of seaweed is photosynthesis, which occurs in semiautonomous organelles, chloroplasts. Red algae contain a pigment termed phycobilin, which forms a covalent bond with a water-soluble protein. Unlike chlorophyll, a fat-soluble pigment that requires extraction with organic solvents, phycobilin is a water-soluble pigment that can be readily purified ([@b8-ijmm-42-02-0789]). Phycobiliproteins (PBPs) are largely divided into three types. The first type is phycoerythrin (PE), a complex between phycoerythrobilin and a protein, which has a scarlet color. The second type is phycocyanin (PC), a complex between phycocyanobilin and a protein, which forms a blue color. The third type is the indigo-blue allophycocyanin (APC), a complex between phycocyanobilin and a protein with a distinct absorption spectrum. These three complexes are all acidic, with isoelectric points of \~4.3. Each type of PBP is further divided into subtypes. PE has three subtypes: B, R and C; PC has two subtypes: C and R; and APC has only one subtype. In *Pyropia yezoensis*, the PBP type depends on its color variation. PBPs have been reported to protect hepatocytes and to have anti-inflammatory and antioxidant effects, indicating their potential application as therapeutic agents ([@b9-ijmm-42-02-0789],[@b10-ijmm-42-02-0789]). Previous studies have extracted, refined and functionally analyzed particular PBPs from cyanobacteria and seaweed ([@b8-ijmm-42-02-0789],[@b10-ijmm-42-02-0789],[@b11-ijmm-42-02-0789],[@b12-ijmm-42-02-0789]). According to a previous report, it was possible to separate three types of PBPs simultaneously from *Lyngbya sp.* ([@b13-ijmm-42-02-0789]). However, there have been no reports on the separation of PBPs from seaweed and their functional analysis. Therefore, the present study aimed to identify proteins separated from laver, seaweed rich in PBPs, using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and to analyze their antioxidant activities.

Reactive oxygen species (ROS) that are generated *in vivo* are a major cause of human aging and disease. The generation of ROS leads to disease through toxic effects on cells and tissues. ROS include free radical species, including superoxide anions, hydroxyl radicals and singlet oxygen, in addition to non-radical species, including hydrogen peroxide (H~2~O~2~). ROS levels are tightly controlled in the body by antioxidant enzymes, including superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx).

The liver is an important tissue responsible for metabolism and the detoxification of nutrients in the human body. Liver injury can be caused by alcohol, viral infection, drug abuse and oxidative stress ([@b14-ijmm-42-02-0789]-[@b16-ijmm-42-02-0789]). In the present study, HepG2 cells were used to examine the antioxidant function of hepatocytes. HepG2 cells were first reported as hepatocellular carcinoma cells, however, certain genes were confirmed to be more similar to hepatoblastoma in 2009 ([@b17-ijmm-42-02-0789],[@b18-ijmm-42-02-0789]). These cells have been used to investigate liver metabolism, development, oncogenesis (chemocarcinogenesis and mutagenesis), and hepatotoxicity in thousands of cases in previous studies ([@b17-ijmm-42-02-0789],[@b19-ijmm-42-02-0789]-[@b26-ijmm-42-02-0789]). HepG2 cells are cancer cells, however, they do not differ from normal liver cells in their detoxification and antioxidant mechanism ([@b18-ijmm-42-02-0789]). In the present study, the HepG2 cell line was used for the antioxidant function of hepatocytes.

PBPs have a variety of bonds between pigments and proteins, and even the same PBP type can include different phycobilins, with the composition influenced by the environment. As reported previously, PBPs are suggested to have potential antioxidant properties ([@b27-ijmm-42-02-0789]). Therefore, the present study aimed to identify PBPs in laver, elucidate their features and evaluate the potential of peptides derived from these PBPs as antioxidant agents.

Materials and methods
=====================

Red algal materials and crude extraction
----------------------------------------

*P. yezoensis* was obtained from Myeongji (Busan, Korea) and stored at −70°C. The frozen samples were lyophilized and homogenized prior to protein extraction. The crude soluble fraction was extracted with 0.1 M sodium acetate buffer (pH 6.0). Samples of *P. yezoensis* (1 g) were mixed with 50 ml sodium acetate buffer for 16 h with continuous shaking at 4°C, and then filtered through Whatman No. 1 filter paper. The extract was then precipitated with methanol and chloroform ([@b28-ijmm-42-02-0789]). Protein material was precipitated to increase the purity and the resulting supernatants were treated with a 2-D Clean-up kit (GE Healthcare Life Sciences, Logan, UT, USA). Protein concentrations were determined using a bicinchoninic acid assay with bovine serum albumin (Thermo Fisher Scientific, Inc., Waltham, MA, USA) as the standard.

Identification of purified proteins
-----------------------------------

For 2D-PAGE analysis, isoelectric focusing was performed as the first dimension and SDS-PAGE as the second dimension, according to the manufacturer\'s protocols (GE Healthcare Life Sciences). Protein samples (150 *µ*g) containing 0.5% immobilized pH gradient (IPG) buffer (pH 4-7) and 5% bromophenol blue were applied to an immobilized IPG DryStrip (pH 4-7, 13 cm, GE Healthcare Life Sciences) and rehydrated for 16 h in lysis solution containing 4 M urea, 4% 3-(3-cholami-dopropyl dimethylammonio) propanesulfonate, 2 M thiourea, 100 mM dithiothreitol and 1% polyvinylpyrrolidone. Prior to performing the second dimension SDS-PAGE, focused IPG strips were equilibrated for 20 min in a solution of 50 mM Tris-HCl (pH 8.8), 6 M urea, 30% glycerol, 2% SDS and 1% DTT, and then for an additional 20 min in the same solution, but with the DTT replaced with 0.5% iodoacetamide. The equilibrated strips were positioned on a 15% polyacrylamide gel (14×13 cm, 1.5 mm) and, following SDS-PAGE the gels were silver-stained. Analysis of the partial amino acid sequences of the soluble proteins was performed using electrospray ionization quadrupole time-of-flight mass spectrometry/mass spectrometry (ESI Q TOF MS/MS), as described previously ([@b29-ijmm-42-02-0789]).

Peptide synthesis
-----------------

The *P. yezoensis* PBP-derived peptides (PBP 1-13) were synthesized by Peptron (Daejeon, Korea). Purification of the 13 peptides was performed on a C18 column (Shiseido CAPCELL PAK; Shiseido, Tokyo, Japan) attached to a high-performance liquid chromatography apparatus with elution in 0.1% trifluoroacetic acid and a gradient of 3-70% acetonitrile, a flow rate of 1 ml/min and UV detection at 220 nm. The peptide molecular weights, as shown in [Table I](#tI-ijmm-42-02-0789){ref-type="table"}, were determined by mass analysis (HP 1100 series LC/MSD; Agilent Technologies, Inc., Santa Clara, CA, USA).

Measurements of cell viability and ROS
--------------------------------------

The HepG2 human hepatoblastoma cell lines were obtained from American Type Culture Collection (Rockville, MD, USA). The cells were cultured at 37°C in a humidified 5% CO~2~, 95% air equilibrated incubator in modified Eagle\'s medium (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) supplemented with heat-inactivated 10% fetal bovine serum (FBS; HyClone, Logan, UT, USA), 100 U/ml penicillin and 100 *µ*g/ml streptomycin. The adherent cells were detached with trypsin-EDTA solution and plated at 70-80% confluence.

Cell viability was measured with fluorescein diacetate (FDA) and propidium iodide (PI), which stain viable cells and dead cells, respectively. The cells were seeded at a density of 1.5×10^4^ cells per well in a 96-well plate. PBP 1-13 (1 *µ*g/ml) were added and the cells were treated with 5 mM H~2~O~2~ for 1 h. The cell culture medium was then removed and FDA (at a final concentration of 10 *µ*g/ml) or PI (at a final concentration of 5 *µ*g/ml) was added. The cells were incubated at 37°C for 30 min. The staining solutions were removed and the samples were washed with phosphate-buffered saline (PBS). In order to determine the experimental concentrations of PBP peptides, a preliminary experiment was performed using 1-100 *µ*g/ml of peptides with FDA and PI. The subsequent experiments were performed using the range of 0.001-0.01-0.1-1 *µ*g/ml, which showed the concentration-dependent changes and suitability in measurement (data not shown).

Inhibition of ROS production by PBP 1-13 was evaluated in the HepG2 cells using a cell permeable probe, 2′,7′-dichlorofluorescein diacetate (DCF-DA). The cells were seeded onto 96-well plates (1.5×10^4^ cells per well), grown until confluence and pre-incubated with 50 *µ*M DCF-DA for 1 h at 37°C in the dark. Following washing with PBS away excess probe, the cells were treated with PBS or PBP 1-13 (1 *µ*g/ml) in the presence or absence of 5 mM H~2~O~2~, for 1 h. Ascorbic acid (1 *µ*g/ml) was used as an antioxidant control.

Fluorescence was measured using a FilterMax F5 Multi-Mode microplate reader (Molecular Devices LLC, Sunnyvale, CA, USA) and an Epi-fluorescence microscope (Nikon Corporation, Tokyo, Japan) with the following settings: Excitation 485 nm and emission 535 nm for FDA and DCF-DA, and excitation 535 nm and emission 615 nm for PI. The viability and ROS production of the synthetic peptide-treated cells were calculated as a percentage of that in the untreated control cells.

Quantitative analysis of living and dead cells according to PBP2 concentrations were performed according to the manufacturer\'s protocol of the FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, Franklin Lakes, NJ, USA) and measured with a Muse™ Cell Analyzer (EMD Millipore, Billerica, MA, USA). To measure the number of stained cells, ImageJ software (version 1.41; National Institutes of Health, Bethesda, MD, USA) was used alongside Cell Counting Macro 1 \[version 1.0; developed by Kurt De Vos (Academic Neurology, University of Sheffield, Shefield, UK) and used by the GNU General Public License, <https://github.com/grishagin/CellCounting/archive/master.zip>\].

The cells were seeded at a density of 1.5×10^4^ cells per well in a 96-well plate. PBP2 (1 *µ*g/ml) was added and the cells were treated with 5 mM H~2~O~2~ for 1 h. The cell culture medium was then removed, and the cells were washed with PBS. The cells were then stained with Annexin V and PI for 15 min in the dark at 25°C.

Western blot analysis
---------------------

Whole cell extracts for the detection of SOD, CAT and GPx by immunoblotting were isolated from the H~2~O~2~-treated HepG2 cells with or without PBP 1-13 peptide treatment. Separation of nuclei was performed using the Nuclei EZ Prep nuclear isolation kit (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) according to the manufacturer\'s protocols. Protein concentration was determined by bicinchoninic acid assay. The cell lysates (30 *µ*g) and nuclei (20 *µ*g) were separated by electrophoresis on a 15% SDS-PAGE gel and transferred onto polyvinylidene difluoride membranes (EMD Millipore) using a semi-dry transfer system. The membranes were blocked with 1% BSA in TBST buffer (0.1% Tween 20 in TBS) overnight at 4°C and incubated with the following primary antibodies: SOD2 (1:2,000; cat. no. OASE00357; Aviva Systems Biology, San Diego, CA, USA), CAT (1:500; cat. no. OAAB05216; Aviva Systems Biology), GPx1 (1:1,000; cat. no. OAAF05777; Aviva Systems Biology), PCNA (1:1,000; cat. no. sc-56, Santa Cruz Biotechnology, Inc., Heidelberg, Germany), β-actin (1:1,000; cat. no. sc-47778; Santa Cruz Biotechnology Inc.), nuclear factor erythroid-derived 2-like 2 (Nrf2; 1:1,000; cat. no. sc-722; Santa Cruz Biotechnology, Inc.); p-Nrf2 (1:5,000; cat. no. ab76026; Abcam, Cambridge, UK) in TBST solution containing 1% BSA for 1 h at room temperature. Following washing three times with TBST, the membranes were incubated for 1 h at room temperature with anti-rabbit and anti-mouse secondary antibodies (Thermo Fisher Scientific, Inc.) with horseradish peroxidase and washed with TBST three times. The final detection was performed with enhanced chemiluminescence western blotting reagents (Santa Cruz Biotechnology, Inc.). GeneTools software (version 4.03; Syngene, Cambridge, UK) was used for densitometry.

Statistical analysis
--------------------

Data are expressed as the mean ± standard deviation and were evaluated by one-way analysis of variance using the statistical package for social sciences version 10.0 (SPSS, Inc., Chicago, IL, USA). Values were compared with controls using one-way analysis of variance followed by Duncan\'s multiple range tests. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

Identification of PBPs
----------------------

Soluble proteins were extracted from *P. yezoensis* and separated by 2D-PAGE. The soluble proteins were classified by their isoelectric points (pIs) using a strip with a pH range of 4-7. As shown in [Fig. 1](#f1-ijmm-42-02-0789){ref-type="fig"}, \~200 spots were resolved. To characterize PBPs with pI values of 4-6, 60 spots observed between 11 and 25 kDa were analyzed by ESI-Q TOF MS/MS. As a result, 10 spots were identified as PBPs (enclosed with circles in the tetragon in [Fig. 1A](#f1-ijmm-42-02-0789){ref-type="fig"}). As shown in [Table I](#tI-ijmm-42-02-0789){ref-type="table"}, the identified PBPs were PE (spots 42, 43, 51, 52 and 54), PC (spots 61 and 59) and APC (spots 47, 48 and 49). PE was identified as the α-type based on peptide sequences analyzed from spots 51, 52 and 54, RFP SSS DLE SVQ GNI QRA, RTL NLP TSA YVA SFA FAR D and KSV ITT TIS AAD AAG RFP SSS DLE SVQ GNI QRA; and as the β-type based on sequences from spots 42, 43 ([Fig. 1B and C](#f1-ijmm-42-02-0789){ref-type="fig"}), 51 and 52, KAA AVA FIT NTA SQR K and RYV SYA LLA GDP SVL EDR C. PC was identified as the α-type with the sequences analyzed from spots 61 and 69, RFL SNG ELQ AIN GRY, RLI TGA AQS VYT KF, KTP ITE AIA SAD SQG RF and KFP YVT QMP GPT YAS SAI GKA. APC-α was identified by the sequences of spots 47 and 48, MQD AIT SVI NAA DVQ GKY, RAA ATI AAN AAT IIK E and RYA TYG MLA GDP SIL EER V, whereas APC-β was identified by the sequence of spot 49, RLV TYG IVA GDV TPI EEI GLV GVK E.

Cell viabilities and ROS inhibition activities of synthetic peptides
--------------------------------------------------------------------

The HepG2 human hepatoblastoma cell line derived from the HepG2 cell line can be used for investigations of xenobiotic metabolism as it maintains the synthesis and secretion of plasma proteins and cell surface receptors, which are specific functions of normal liver parenchymal cells ([@b18-ijmm-42-02-0789],[@b19-ijmm-42-02-0789]). This was performed in the present study to confirm the protective effect of PBP peptides on oxidative stress and liver injury induced by the H~2~O~2~ in *vitro* system. As the liver is central for detoxification *in vivo*, HepG2 cell line, which is a human liver cell, was used as a target to observe the protective effect of oxidative stress.

The synthetic peptides, listed in [Table I](#tI-ijmm-42-02-0789){ref-type="table"}, were administered at 1 *µ*g/ml to the HepG2 human liver cells, and their viabilities and ROS inhibition activities were determined. The fluorescent indicator dyes DCF-DA, FAD and PI load readily into guard cells, and their optical properties make them amenable to analysis using a fluorescence spectrophotometer. As shown in [Fig. 2A](#f2-ijmm-42-02-0789){ref-type="fig"}, the number of viable cells was reduced to 47% by 5 mM H~2~O~2~. PBP1, 2 and 7-9 increased the number of viable cells by 23-32%, whereas dead cells stained with PI increased 2.3-fold by 5 mM H~2~O~2~ ([Fig. 2B](#f2-ijmm-42-02-0789){ref-type="fig"}). PBP 1-13 reduced dead cells by 30-143%. In particular, PBP2 decreased to the negative control level. The ratio of viable cells to dead cells was reduced to 0.23 by 5 mM H~2~O~2~, but recovered in the presence of PBP1-4, 7-9 and 12 ([Fig. 2C](#f2-ijmm-42-02-0789){ref-type="fig"}). In particular, PBP1-2 led to recovery with a ratio over three times higher than that of the positive control. Treatment with 5 mM H~2~O~2~ increased the production of ROS \~2-fold compared with that of the negative control ([Fig. 2D](#f2-ijmm-42-02-0789){ref-type="fig"}). PBP 1, 2, 7-9 and 11-13 led to a 17-56% reduction in the production of ROS compared with that of the positive control. As a result, PBP 1, 2, 7-9 and 12 protected cells from oxidative stress by H~2~O~2~ and exhibited an antioxidative effect.

In particular, PBP2 showed good efficacy in terms of cell survival, prevention of death and inhibition of ROS production compared with 1 *µ*g/ml ascorbic acid, a well-known antioxidant.

Effects of PBP2 under H~2~O~2~-induced oxidative stress in HepG2 cells
----------------------------------------------------------------------

The HepG2 cells were stained with DCF-DA, PI, Annexin V and FDA, and observed with a fluorescence microscope and a fluorescence absorbance spectrophotometer to determine cytoprotective activity and antioxidant activity according to the concentration of PBP2 (0.001-1 *µ*g/ml). The viable cell number decreased in the presence of 5 mM H~2~O~2~, whereas the number of dead cells and ROS increased ([Fig. 3A and B](#f3-ijmm-42-02-0789){ref-type="fig"}). PBP2 at concentrations of 1 *µ*g/ml increased the number of living cells and restored apoptotic cells and dead cells to negative control levels. In addition, 0.1-1 *µ*g/ml PBP2 reduced the production of ROS by \>50% when compared with that of the positive control.

PBP2 upregulates the protein expression of p-Nrf2 and antioxidant enzymes
-------------------------------------------------------------------------

To examine the possible mechanisms underlying the antioxidative effect, the present study investigated the effects of 1 *µ*g/ml PBP2 on the p-Nrf2/antioxidant enzyme (CAT, SOD and GPx) pathway in HepG2 cells. As shown in [Fig. 4A and B](#f4-ijmm-42-02-0789){ref-type="fig"}, HepG2 cells exposed to 5 mM H~2~O~2~ showed a significant decrease in the level of p-Nrf2. However, a marked increase in the level of p-Nrf2 was detected in the 0.1-1 *µ*g/ml PBP2-treated groups. The expression levels of CAT and GPX were not significantly affected by 5 mM H~2~O~2~, however, SOD was decreased by 5 mM H~2~O~2~ and increased by treatment with PBP2 ([Fig. 4C and D](#f4-ijmm-42-02-0789){ref-type="fig"}). GPX was not affected by 5 mM H~2~O~2~, but was increased by the effect of PBP2, suggesting that it was used to reduce the increased ROS. This increase was not concentration-dependent in the range of 0.01-1 *µ*g/ml, suggesting that the removal of ROS used antioxidant enzymes other than SOD and GPX. The present study did not examine all the antioxidant enzymes and mechanisms, but confirmed the possibility. Therefore, the results of the present study may assist in elucidating the more specific mechanism of PBP2.

The results showed that treatment with 5 mM H~2~O~2~ led to decreases in the expression of p-Nrf2 and SOD, which were reversed by treatment with 0.1-1 *µ*g/ml PBP2. However, no significant difference in the protein level of CAT was observed among these groups. These data suggested that PBP2 controlled H~2~O~2~-induced oxidative stress by regulating the expression of p-Nrf2/SOD.

Discussion
==========

PBPs have been described as having potent antioxidant activities and are used as pharmaceutical agents based on such reported activities ([@b9-ijmm-42-02-0789],[@b10-ijmm-42-02-0789],[@b12-ijmm-42-02-0789],[@b13-ijmm-42-02-0789],[@b30-ijmm-42-02-0789]-[@b32-ijmm-42-02-0789]). In the present study, various physiological activities of PBP were isolated and identified from *P. yezoensis*.

PE is a hexamer in dilute acidic solutions. The monomer has two peptide chains, α and β, each with a molecular weight of 19.5 kDa. Therefore, the total molecular weight of the monomer is 39 kDa. PE acquires a scarlet color by binding to phycoerythrobilin, a pigment that normally has a minimal absorption spectrum of 498, 540 and 565 nm, and, typically, two or three molecules bind with one another. Red algae contain phycoerythrobilin and phycourobilin, with a maximum absorbance of 490 nm and, typically, two molecules bind to the protein. Certain types of PE show different intensities in the absorption bands and have different absorption spectra; however, in the majority of cases, PE has a maximum band of fluorescence emission at 552 nm ([@b33-ijmm-42-02-0789],[@b34-ijmm-42-02-0789]). In the present study, *P. yezoensis* tissue underwent a lysis protocol, resulting in the majority of protein complexes dissociating to yield proteins in only the monomer form, which were then analyzed by 2D-PAGE. As a result, two types of PE were observed at 19 kDa. However, PC-β was not observed in the protein samples analyzed in the present study. PC in seaweed is usually a monomer with a molecular weight of 40 kDa, and is composed of an α-chain with a molecular weight of 18.5 kDa and β-chain with a molecular weight of 20.5 kDa, and two or three blue-colored phycocyanobilin molecules bind with one phycoerythrobilin molecule ([@b35-ijmm-42-02-0789],[@b36-ijmm-42-02-0789]). PC in red algae is the R-type with an absorption band between 615 and 620 nm, however, certain types show an absorption band at 550 nm, caused by phycoerythrobilin ([@b33-ijmm-42-02-0789]).

In APC, a monomer with a molecular weight of 15.5 kDa forms a hexamer ([@b35-ijmm-42-02-0789],[@b36-ijmm-42-02-0789]). APC is less abundant than PE or PC and, like PC, has a bond between phycocyanobilin and the protein. However, it differs from PE and PC in its absorption spectrum, showing maximum absorption bands at 620 and 650 nm ([@b33-ijmm-42-02-0789]).

Color mutations in *P. yezoensis* yield, in addition to the wild-type, a red type, a green type and a yellow type, all of which have different types of phycobilin ([@b37-ijmm-42-02-0789]). The wild-type consists of R-PE and C-PC; the red type consists of R-PE and R-PC; the green type consists of B-PE and C-PC; and the yellow type consists of B-PE and R-PC. APC occurs in all these genotypes. The present study used the red-type *P. yezoensis* and its R-PE was identified in spots 5, 42, 43 and 51. However, PC could not be classified in present study. Presumably, PC was dissolved or dissociated by the reagent used in the pretreatment process for 2D-PAGE and ESI Q TOF, and thus was not classified or detected.

Marine organisms, including seaweeds, contain various chemical agents, including fatty acids, carotenoids, polysaccharides and pigment proteins, all showing diverse biological activities ([@b1-ijmm-42-02-0789]-[@b5-ijmm-42-02-0789],[@b31-ijmm-42-02-0789]). In particular, several studies have focused on the potential biochemical applications of peptides originating from marine organism-derived proteins ([@b32-ijmm-42-02-0789]). The diversity of such applications is based potentially on the essential amino acid compositions of these proteins.

In the present study, the antioxidant activity was confirmed by synthesizing the identified PBP. No cytotoxicity was observed for the 13 synthetic peptides assessed, as shown in [Fig. 2C](#f2-ijmm-42-02-0789){ref-type="fig"}. The percentage of cells that survived oxidative stress was observed to increase when the cells were treated with the synthesized peptides. Therefore, the peptides showed no toxicity in these cell culture experiments. The intracellular ROS levels, measured with DCF-DA, increased 2-3-fold in cells treated with H~2~O~2~ and these values decreased when treated with certain peptides. The ROS levels were found to decrease by up to 56% in the presence of PBP2 (synthesized from PE), as shown in [Fig. 2D](#f2-ijmm-42-02-0789){ref-type="fig"}. The ROS levels were reduced by PBP 1, 2 (synthesized from the PE β subunit), 7-9 (synthesized from PE α subunit) and 10-12 (synthesized from PC), demonstrating the antioxidant properties of PE and PC. For several decades, several *in vitro* and *in vivo* studies have been performed on the potential removal of free radicals by PBPs. Sonani *et al* reported on external antioxidant and free radical removal activities of three types of PBP extracted from *Lyngbya sp*., a cyanobacterium ([@b13-ijmm-42-02-0789]). PE exhibited antioxidant activity by removing ROS through direct oxidation-reduction reactions, whereas PC and APC exhibited antioxidant activities through indirect mechanisms, including metal ion chelation. Such reports indicate that the antioxidant activities of PBPs occur by various mechanisms and the mechanism is dependent on amino acid side chains of these PBPS. Here, it was hypothesized that the distribution of the amino acids on the surface of PBPs defines their diverse antioxidant activities. The peptides synthesized from PE types of *P. yezoensis* also showed activity that reduced ROS levels. In the present study, the antioxidant activities attributed to PBPs were evaluated by synthesizing shorter peptide fragments of PBPs rather than full-length proteins in an effort to identify novel candidate peptides for experiments on antioxidant and anti-aging activities.

Amino acids with hydrophobic branch chains are good proton donors and metal ion chelation agents. Similarly, acidic, basic and aromatic amino acids facilitate the removal of metal ions ([@b38-ijmm-42-02-0789]). PBPs have been reported to be metal ion chelation agents, and thus effective at removing metals. It has been suggested that certain antioxidant activities of PBPs are attributable to proton donation or metal ion chelation, both dependent on amino acid composition ([@b13-ijmm-42-02-0789],[@b39-ijmm-42-02-0789]). In particular, it was reported that PE has low chelation capability but a high reduction capacity when compared with that of PC or APC, indicating that PE and PC may be important in oxidation-reduction reactions and, therefore, in antioxidant activities ([@b27-ijmm-42-02-0789]). The peptides synthesized from PE exhibited higher ROS removal activities compared with the peptides synthesized from PC or APC.

When oxidative stress occurs in a cell, the cell activates several processes to reduce this stress ([@b40-ijmm-42-02-0789]). One of these processes is to increase antioxidant enzyme levels through the Nrf2/antioxidant responsive element (ARE) pathway. Nrf2 enters the nucleus and converts to p-Nrf2, which activates ARE. This allows the expression of antioxidant enzymes, including CAT, SOD and GPx, and is used to eliminate oxidative stress. In the present study, PBP2 increased the expression of p-Nrf2, a typical antioxidant stress reliever. In addition, PBP2 increased the expression of antioxidant enzymes SOD and GPx. PBP2 was able to inhibit ROS production directly by increasing the activity of p-Nrf2 and SOD. The subsequent experiments corroborated these findings.

Various biomolecules with potent antioxidant activities have been examined for the prevention of aging. Aging is defined as systematic decreases in physiological functions, including biochemical functions, occurring in the majority of organisms. According to the free radical theory of aging, a major cause is activated oxygen species and, therefore, removal of such species is being investigated for the prevention of aging. The present study was performed to address whether certain peptides, derived from PBPs, with identified antioxidant activities may be useful for the prevention of aging. The findings identified several peptides as candidate antioxidant agents. The aim of the present study was to analyze the signaling pathways involved in the mechanism of action of peptides synthesized from PBPs, demonstrating their antioxidant activities in cells and addressing their potential value as antioxidant agents.

In the present study, PBPs from *P. yezoensis* were identified by proteomics and several PBP peptides were synthesized to examine their inhibition of ROS generation. Several synthesized PBPs peptides showed antioxidant activities in HepG2 cells. In particular, the PBP2 peptide was identified as a potential antioxidant as this peptide downregulated ROS, and appeared to function through the p-Nrf2/SOD pathways. In conclusion, PBP2 attenuated H~2~O~2~-induced oxidative stress in the HepG2 cells.
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![Proteome reference map of *P. yezoensis.* (A) Isoelectric focusing was performed with a soluble protein extract of *P. yezoensis* using a 13-cm pH 4-7 immobilized gradient strip, followed by SDS-PAGE on a 12% acrylamide gel and then visualized by silver staining. The enlarged square indicates the position of the identified protein by ESI Q TOF MS/MS. The numbers refer to the protein identities shown in [Table I](#tI-ijmm-42-02-0789){ref-type="table"}. (B) ESI Q TOF MS spectrum (arrow: Amino acid sequence analysis by MS/MS) and (C) MS/MS spectrum of spot 43. *P. yezoensis, Pyropia yezoensis*; ESI Q TOF MS, electrospray ionization quadrupole time-of-flight mass spectrometry.](IJMM-42-02-0789-g00){#f1-ijmm-42-02-0789}

![Effects of synthetic PBP peptides in HepG2 cells. Induction of 5 mM H~2~O~2~-induced cell toxicity and the effects of synthetic peptides. Live cells and dead cells were stained with (A) fluorescein diacetate and (B) propidium iodide. (C) Ratio of live cells/dead cells. (D) Effects of the synthetic peptides on the formation of H~2~O~2~-induced ROS. Cells were pretreated with 2′,7′-dichlorofluorescin diacetate. Values are expressed as the mean ± standard deviation (n=3). ^\*^P\<0.05, vs. untreated control; ^\#^P\<0.05, vs. 5 mM H~2~O~2~-treated control. ^\#\#^P\<0.01, vs. 5 mM H~2~O~2~-treated control. -, control cells without 5 mM H~2~O~2~; +, control cells treated with 5 mM H~2~O~2~; PBP, phycobiliprotein; AA, 1 *µ*g/ml ascorbic acid; H~2~O~2~, hydrogen peroxide; ROS, reactive oxygen species; Con, control.](IJMM-42-02-0789-g01){#f2-ijmm-42-02-0789}

![PBP2 resorted 5 mM H~2~O~2~-induced oxidative stress in HepG2 cells. (A) Live cells, apoptotic cells, dead cells and ROS were detected by fluorescein diacetate, propidium iodide, Annexin V and 2′,7′-dichlorofluorescein diacetate staining. Scale bar=100 *µ*m. (B) Fluorescence intensity was analyzed using ImageJ software and the Muse™ cell analyzer. Values are expressed as the mean ± standard deviation (n=3). ^\*^P\<0.05, vs. untreated control; ^\#^P\<0.05, vs. 5 mM H~2~O~2~-treated control; ^\#\#^P\<0.01, vs. 5 mM H~2~O~2~-treated control. -, control cells without 5 mM H~2~O~2~; +, control cells treated with 5 mM H~2~O~2~; PBP2, phycobiliprotein 2; H~2~O~2~, hydrogen peroxide; ROS, reactive oxygen species; Con, control.](IJMM-42-02-0789-g02){#f3-ijmm-42-02-0789}

![Effects of PBP2 on protein expression levels of CAT, SOD and GPx in H~2~O~2~-treated HepG2 cells. (A) Western blot analysis of protein levels of p-Nrf2. (B) Data quantification of protein expression of Nrf2 and p-Nrf2. (C) Western blot analysis of antioxidant enzyme levels. (D) Data quantification of antioxidant enzyme/β-actin protein expression. Values are expressed as the mean ± standard deviation (n=3). ^\*^P\<0.05, vs. untreated control; ^\#^P\<0.05, vs. 5 mM H~2~O~2~-treated control; ^\#\#^P\<0.01, vs. 5 mM H~2~O~2~-treated control. -, control cells without 5 mM H~2~O~2~; +, control cells treated with 5 mM H~2~O~2~; PBP2, phycobiliprotein 2; Nrf2, nuclear factor erythroid-derived 2-like 2; p-Nrf2, phosphorylated Nrf2; CAT, catalase; SOD, superoxide dismutase; GPx, glutathione peroxidase; Con, control; AEs, antioxidant enzymes.](IJMM-42-02-0789-g03){#f4-ijmm-42-02-0789}

###### 

Identification of two-dimensional polyacrylamide gel electrophoresis spots and synthesis of peptides based on phycobiliproteins from *Pyropia yezoensis*.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Spot                      Identification              Database/accession no.   Taxonomy                            Sequence                PI       Nominal mass (M~r~)   Score   Protein sequence coverage (%)   Synthesized peptide
  ------------------------- --------------------------- ------------------------ ----------------------------------- ----------------------- -------- --------------------- ------- ------------------------------- ---------------------
  42                        R-phycoerythrin β chain     SwissProt/PHEB_PYRHA     *Pyropia haitanensis*               KAAAVAFITNTASQRK        6.23     18,817                47      7                               PBP1

  43                        Phycoerythrin β subunit     NCBI/gi\|73761963        *Aglaothamnion callophyllidicola*   KAAAVAFITNTASQRK        5.41     17,570                71      8                               PBP1

  R-phycoerythrin β chain   SwissProt/PHEB_PORPU        *Porphyra purpurea*      RYVSYALLAGDPSVLEDRC                 6.23                    18,833   63                    9       PBP2                            

  47                        Allophycocyanin β subunit   NCBI/gi\|11465727        *Porphyra purpurea*                 MQDAITSVINAADVQGKY      5.17     17,589                85      10                              PBP3

  48                        Allophycocyanin β subunit   NCBI/gi\|11465727        *Porphyra purpurea*                 MQDAITSVINAADVQGKY\     5.17     17,589                210     29                              PBP3\
                                                                                                                     RAAATIAANAATIIKE\                                                                              PBP4\
                                                                                                                     RYATYGMLAGDPSILEERV                                                                            PBP5

  49                        Allophycocyanin α chain     NCBI/gi\|129987          *Aglaothamnion neglectum*           RLVTYGIVAGDVTPIEEI\     4.78     17,648                81      14                              PBP6
                                                                                                                     GLVGVKE                                                                                        

  51                        Phycoerythrin β subunit     NCBI/gi\|73761963        *Aglaothamnion callophyllidicola*   KAAAVAFITNTASQRK        5.41     17,570                71      8                               PBP1

  Phycoerythrin α subunit   NCBI/gi\|2317690            *Pyropia yezoensis*      RFPSSSDLESVQGNIQRA                  5.40                    17,587   103                   9       PBP7                            

  R-phycoerythrin α chain   NCBI/gi\|3914333            *Pyropia tenera*         KSVITTTISAADAAGRFPS\                5.40                    17,887   91                    18      PBP8                            
                                                                                 SSDLESVQGNIQRA                                                                                                                     

  52                        Phycoerythrin β subunit     NCBI/gi\|73761963        *Aglaothamnion callophyllidicola*   KAAAVAFITNTASQRK        5.41     17,570                69      8                               PBP1

  Phycoerythrin α subunit   NCBI/gi\|2317690            *Pyropia yezoensis*      RFPSSSDLESVQGNIQRA\                 5.40                    17,857   94\                   9\      PBP7\                           
                                                                                 RTLNLPTSAYVASFAFARD                                                  78                    10      PBP9                            

  54                        Phycoerythrin α subunit     NCBI/gi\|2317690         *Pyropia yezoensis*                 RFPSSSDLESVQGNIQRA      5.40     17,857                77      9                               PBP7

  61                        Phycocyanin α subunit       NCBI/gi\|90994569        *Pyropia yezoensis*                 RFLSNGELQAINGRY\        7.71     17,569                90      15                              PBP10\
                                                                                                                     RLITGAAQSVYTKF                                                                                 PBP11

  69                        Phycocyanin α subunit       NCBI/gi\|11465844        *Porphyra purpurea*                 KTPITEAIASADSQGRF\      7.71     17,555                96      20                              PBP12\
                                                                                                                     KFPYVTQMPGPTYASSAIGKA                                                                          PBP13
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
